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CO = cardiac output; CVP = central venous pressure; DO2 = oxygen delivery; dp/dt max = maximum rate of rise of ventricular pressure; EF = ejec-
tion fraction; EVLW = extravascular lung water; Hb = hemoglobin concentration; ICU = intensive care unit; NIRS = near-infrared spectroscopy;
PAC = pulmonary artery catheter; PAOP = pulmonary artery occlusion pressure; ptiO2 = oxygen partial pressure in tissues; RF = residual fraction;
RVEDV = right ventricular end-diastolic volume; RVEF = right ventricular ejection fraction; SaO2 = arterial oxygen saturation; SV = stroke volume;
SvO2 = venous oxygen saturation; TEE = transesophageal echocardiography; TTE = transthoracal echocardiography; VO2 = oxygen consumption.
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“Not everything that counts can be counted
and not everything that can be counted counts”
(Albert Einstein)
Improvements in surgical techniques and perioperative anes-
thetic management have led to enhancement of surgery and
intensive care therapy for patients who would never before
have been acceptable candidates. Ongoing developments in
monitoring techniques have shed new light on our knowl-
edge of pathophysiological processes associated with criti-
cal illness.
Since the first public demonstration of modern anesthesia in
Boston in 1846 there has been a tremendous increase in
monitoring devices, especially in the past 30 years. Modern
technology has provided a large number of sophisticated
monitors. Most of these newly developed techniques have
enhanced our understanding of the mechanism of patient
decompensation and have helped to guide appropriate thera-
peutic interventions. Aggressive marketing strategies have
been promoted to monitor a variety of functions. However, it
still remains unclear whether they are able to enhance patient
safety or even improve patient outcome.
What is so specific in monitoring the
intensive care unit patient?
Multiple organ dysfunction syndrome accounts for most
deaths in the intensive care unit (ICU). Patients who develop
this complication place an enormous burden on all hospital
services, especially intensive care. Although the exact patho-
physiology of multiple organ dysfunction syndrome is not yet
definitely known, alterations in systemic hemodynamics,
organ perfusion and tissue microcirculation resulting in tissue
hypoxia appear to play a key role in the onset and mainte-
nance of this syndrome. Pflueger stated in 1872 that “arterial
oxygen content, arterial pressures, velocity of blood stream,
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Abstract
Since the beginning of modern anesthesia, in 1846, the anesthetist has relied on his natural senses to
monitor the patient, aided more recently by simple technical devices such as the stethoscope. There
has been a tremendous increase in the availability of monitoring devices in the past 30 years. Modern
technology has provided a large number of sophisticated monitors and therapeutic instruments,
particularly in the past decade. Most of these techniques have enhanced our understanding of the
mechanism of the patients’ decompensation and have helped to guide appropriate therapeutic
interventions. As surgery and critical care medicine have developed rapidly, patient monitoring
capability has become increasingly complex. The most important aspect in monitoring the critically ill
patient is the detection of life-threatening derangements of vital functions. Aggressive marketing
strategies have been promoted to monitor almost every aspect of the patient’s status. However, these
strategies are only telling us what is possible; they do not tell us whether they enhance patient safety,
improve our therapy, or even improve patient outcome.
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mode of cardiac work, mode of respiration are all incidental
and subordinate; they all combine to service the cell” [1].
Optimal monitoring of the critically ill ICU patient remains a
challenge. Controversy continues as to whether the patient will
profit from a more aggressive monitoring. Unfortunately, our
current understanding of this area is poor. Time appears to be
crucial for an early diagnosis of hemodynamic catastrophe and
earlier therapy appears to improve outcome in this situation.
Possibilities for systemic hemodynamic
monitoring
Monitoring of cardiac function
The assessment of ventricular function is based on the mea-
surement of both volumes and pressures. By relating
changes in left ventricular volume or pressure to time during
phases of the cardiac cycle, indices of contractility can be
generated. These indices include fractional shortening, mean
circumferential shortening, the maximum rate of rise of ven-
tricular pressure (dp/dt max), and ejection fraction (EF).
The difficulty of evaluating cardiac performance is reflected
by the number of hemodynamic variables, which are thought
to be indicators of myocardial function [2]. Some variables
can be measured only in experimental settings and not in clin-
ical practice. Left ventricular dp/dt max has been widely
accepted as an index of the contractile performance of the
left ventricle. Despite theoretical objections, it is accepted
that measurement of left ventricular dp/dt max is a satisfac-
tory index of ventricular contractility.
The most widely accepted technique for measuring cardiac
output (CO) is the thermodilution method using a pulmonary
artery catheter (PAC) and a bedside microprocessor. This
technique is easy to perform without any risk of indicator
accumulation, and can thus be carried out sequentially and
multiple times even in the critically ill.
Singer promotes CO measurement non-invasively by the
transthoracic electrical impedance technique or by trans-
esophageal Doppler sonography [3]. However, results are
very controversial [4–7]: some investigators state that the
transthoracic electrical impedance method compares well
with the CO estimates by thermodilution; others, however, find
this technique unreliable when compared with other methods,
particularly in those patients with altered lung function.
PAC monitoring
The introduction of flow-directed PAC has not only revolution-
ized monitoring in intensive care medicine, but has also con-
tributed to improving our knowledge of cardiovascular
function. It is a relatively simple and safe procedure, which
produces information relevant to certain aspects of cardiopul-
monary function in a variety of circumstances [8]. The PAC
monitoring instrument enables us to obtain direct information
on pressure variables such as pulmonary artery pressure, pul-
monary capillary wedge pressure (better named pulmonary
artery occlusion pressure [PAOP]) and right atrial pressure,
as well as flow variables such as (continuous) CO. Common
formulae allow us to calculate further determinants of the car-
diovascular system (e.g. systemic vascular resistance, pul-
monary vascular resistance, right ventricular stroke work, and
left ventricular stroke work).
Since the introduction of the PAC by Swan in the 1970s,
more than 2 million PACs have been inserted. The value, limi-
tations, and indications of the PAC are still controversially dis-
cussed. Some authors have demonstrated that a PAC can be
helpful in the early diagnosis of subendocardial ischemia [9],
and others have shown that even the experienced intensivist
failed to diagnose significant hemodynamic alteration in the
absence of a PAC [10]. The value of elevated PAOP or
abnormal wave patterns in the wedge tracing as indicators of
ischemia remains controversial. Gore et al. [11] have shown
that patients who suffered from acute myocardial infarction
and who were monitored with a PAC had a worse outcome
than patients treated without a PAC. Other workers have con-
cluded that, in patients who are at high risk of suffering
myocardial ischemia, there was no significant difference
regarding outcome or postoperative complications whether
they were managed with a central venous pressure (CVP)
catheter or a PAC [12].
Measurement of PAOP does not always reflect end-diastolic
volume. The CVP and PAOP parallel each other with a high
degree of correlation in the perioperative period in patients
with EF >50% [13]. In patients with severely impaired
myocardial function (EF <40%), no more correlation between
the CVP and PAOP could be demonstrated, most probably
due to changes in myocardial compliance caused by myocar-
dial hypertrophy or a stiff left ventricle secondary to ischemia
or cardiac surgery procedures.
The list of potential complications when using a PAC for
monitoring the critically ill is large. Infections are one of the
most important risks, particularly in enhanced periods of
PAC monitoring. Sise et al. [14] found an increase in infec-
tion and an increase in the incidence of catheter fault with
approximately 20% of catheters after 6–7 days. However,
complications are few in skilled, experienced hands and can
be readily anticipated.
Further developments of PAC-based hemodynamic
monitoring
Mixed venous oxygen saturation
PACs do not only help to measure pressure and flow vari-
ables, but there have been a lot of developments in the PAC
equipment that provide further information on the patients’
state. Continuous monitoring of venous oxygen saturation
(SvO2) by fiberoptic reflectometry is another adjunct to hemo-
dynamic monitoring of the critically ill patient. The advantage
of this technique is the ability to realize immediate indicationsCritical Care    February 2002 Vol 6 No 1 Boldt
of both trends and abrupt changes in the oxygen-supply-to-
demand ratio at the bedside [15]. SvO2 has been promoted
as an indicator of changes in CO. Normal values for SvO2
range from 70 to 75%. A linear correlation has been demon-
strated between these CO and SvO2. This correlation,
however, is not actually linear but curvilinear, and only if
oxygen consumption (VO2) and arterial oxygen content do
not change is this relationship true. SvO2 only reflects the
overall oxygen reserve of the whole body. A normal SvO2
value, for instance, does not rule out an impaired oxygen
supply to individual organs [16].
Monitoring of the right ventricle
The focus of interest in hemodynamic monitoring has been on
the ‘dominant’ left side of the heart. The tendency to ‘over-
look’ the right ventricle as an important part of the circulatory
system occurred because it was traditionally regarded as a
passive conduit, responsible for accepting venous blood and
pumping it through the pulmonary circulation to the left ventri-
cle [17]. Maintenance of normal circulatory homeostasis
depends on an adequate function of both ventricles.
Changes in dimension and performance of one ventricle influ-
ence the geometry of the other.
There is growing interest in the importance of the neglected
right side of the heart, particularly in patients suffering from
sepsis and acute respiratory dysfunction syndrome, and in
heart-transplanted patients [18]. Commonly monitored para-
meters such as CVP, right atrial pressure or right ventricular
pressure have been demonstrated to be invalid for judging
right ventricular function or right ventricular loading condi-
tions [19]. Hoffman et al. [20] demonstrated no correlation
between CVP and right ventricular end-diastolic volume
(RVEDV), and they emphasized that the preload factor in the
original Frank–Starling hypothesis had nothing to do with
pressure but concerned volume. Moreover, the use of RVEDV
and right ventricular ejection fraction (RVEF) is unaffected by
arbitrary and poorly reproducible zero points for pressure
transducers. Right ventricular performance is difficult to
measure by other conventional monitoring techniques
because of the functional anatomy and complex geometry of
the right ventricle [21]. Measurement of RVEF by thermodilu-
tion is an easy technique to perform with no accumulation of
toxic indicators based on the use of a fast response thermis-
tor that allows an accurate detection of a rapid step change
of the staircase curve of the downstream temperature
change. The principle of this method is based on the ther-
modilution technique. The catheter is equipped with a fast
response thermistor and electrodes for intracardiac ECG
recording. The typical downslope thermodilution washout
curve follows an exponential decay, interrupted by the dias-
tolic plateaux. The ratio between the temperature change of
two successive diastolic plateaux represents the fraction of
blood remaining in the right ventricle (the residual fraction
[RF]). The RVEF is calculated from the equation EF = 1 – RF.
The thermistor of the new catheter is able to measure beat-to-
beat temperature variations of the downstream temperature
changes after injection of 10 ml ice-cold dextrose. As the CO
and stroke volume (SV) are also calculated by the micro-
processor, RVEDV can be derived from SV/RVEF and the
right ventricular end-systolic volume from RVEDV – SV.
The accuracy and validity of this technique have been shown
using radionuclear methods in humans as well as in animal
experiments, and it has been proved to be valid and accurate
for measuring right ventricular volumes (and RVEF) in com-
parison with radiographic, radionuclide, and echocardio-
graphic methods [22]. Further development of computer
techniques allows continuous monitoring of right ventricular
hemodynamics. Monitoring of right ventricular data may con-
tribute to the evaluation of the patients’ prognosis [18].
However, no large clinical trials are available showing a bene-
ficial impact of RVEF monitoring on patient outcome.
To Swan or not to Swan?
Hemodynamic monitoring using the invasive pulmonary artery
balloon-tip thermodilation catheter has been the gold stan-
dard for evaluation of circulatory function for several years.
The impact of the PAC on patient outcome has been ques-
tioned in a variety of studies. The question “to catheterize or
not to catheterize” is not new [23,24]. The controversy culmi-
nated with the Connors et al. study published in 1996 [25], in
which a higher mortality rate was reported in patients in
whom a PAC was inserted than in those patients treated
without a PAC. Unfortunately, this study was retrospective
not randomized, and the controls were case-matched using a
controversial propensity score. The Connors et al. study [25]
has influenced several reviews on the worth of pulmonary
artery catheterization and calls for a moratorium on the use of
PACs. In a Medline-based meta-analysis reviewing 12 ran-
domized, controlled trials including 1610 patients, a signifi-
cant reduction in morbidity was shown when a PAC-guided
therapeutic strategy was used [26]. Although PAC-based
hemodynamic management has been shown to be successful
in improving outcome in planned major surgery [27], this
benefit has not been translated to the ICU patient. In a study
in surgical patients admitted to the ICU after developing
organ failure, Gattinoni et al. [28] failed to show improved
outcome with therapies aimed at maintaining either oxygen
delivery or SvO2 at supranormal values. In a meta-analysis,
Heyland et al. [29] demonstrated that a therapy targeted at
supraphysiologic endpoints (oxygen delivery, VO2) was not
associated with decreased mortality. Boyd and Bennett [30]
demonstrated with the help of a meta-analysis that outcome
was not improved when therapy attempting to improve tissue
perfusion was started in patients in whom sepsis and organ
failure had already occurred (Fig. 1). When PAC-guided man-
agement was carried out earlier, however, a significant
outcome improvement was seen (Fig. 2). Finally, in a consen-
sus conference on the PAC [31], it was found that there is
insufficient evidence to fully determine whether PAC-guided
therapy significantly alters outcome; more prospective, ran-domized clinical trials are therefore recommended. Although
the PAC-based monitoring has its limitations and pitfalls, it
has proven to still be an established technique for monitoring
the hemodynamics of the ICU patient.
Measurement of extravascular lung water and
intrathoracic blood volume
The most common method for evaluating lung water content
is based on the double-indicator dilution technique using
indocyanine green as the non-diffusible indicator prepared in
ice-cold dextrose (a diffusible indicator) [32]. Absolute values
of extravascular lung water (EVLW) appear to be less impor-
tant than intra-individual changes. Other techniques for
assessing pulmonary fluids are either invalid or too bulky and
expensive (e.g. computerized tomography and nuclear mag-
netic resonance imaging). One of the fundamental lesions in
inflammation is an altered capillary integrity resulting in an
increase in (pulmonary) endothelial permeability. Depressed
left ventricular performance increases hydrostatic pressure in
the pulmonary circulation, synergistically influencing fluid flux
across a damaged pulmonary microvascular membrane.
EVLW can be rapidly and safely measured at the bedside,
although femoral arterial cannulation is believed to be danger-
ous in patients receiving high doses of vasopressors [33].
The double-dye technique needs indocyanine green for the
measurement process, which adds considerable costs.
Blood volume is mostly indirectly inferred from measurement
of arterial pressure, heart rate, CVP, and PAOP. However,
these variables appear to be unreliable indicators of hypov-
olemia. Correct determination of cardiac filling pressures by
PAOP may be difficult under various circumstances (e.g. in
ventilated patients with large excursions in intrathoracic pres-
sure) [34], and intrathoracic blood volume appears to be a
more reliable indicator of preload than the cardiac filling pres-
sures are [35]. Using EVLW and intrathoracic blood volume
monitoring, a reduction in ICU stay and hospital stay was
shown [36,37], and even mortality was demonstrated to be
reduced [38].
Echocardiography
Our monitoring armamentarium has been enhanced signifi-
cantly by the introduction of imaging techniques [39].
Esophageal Doppler has been reported to be an alternative
to the PAC [40]. Assessing global and regional left ventricu-
lar function is the domain of echocardiography (either
transthoracal echocardiography [TTE] or transesophageal
echocardiography [TEE]). Two-dimensional echocardiogra-
phy provides important information about cardiac function
and structure including left ventricular cavity size, fractional
shortening and regional wall motion abnormalities [41]. Infor-
mation on the presence and extent of ischemic heart disease
is possible by monitoring segmental wall motion abnormali-
ties. These abnormalities, however, are only indirect markers
of myocardial perfusion that can persist for prolonged periods
in the absence of infarction. TEE seems to provide more
accurate information on ventricular size than standard moni-
toring instruments. End diastolic volume was a better predic-
tor of myocardial performance than PAOP. Two-dimensional
colored echocardiography allows quantification of shunts,
CO and non-invasive assessment of concomitant valvular
disease. Data obtained by echocardiography may have signif-
icant impact on a patient’s treatment [42]. Echocardiography
is the first diagnostic method used on suspicion of aortic dis-
section, endocarditis, and pulmonary embolism with hemo-
dynamic instability. Hypovolemia, left ventricular failure, global
systolic function and size of both ventricles can rapidly be
diagnosed using TTE/TEE. Finally, valvular abnormalities and




Odds ratio and 95% confidence interval for studies (total of 1031
patients) attempting to improve tissue perfusion after onset of tissue
hypoxic can be expected. No beneficial effect on mortality was seen.
(Modified from [30].)
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Figure 2
Odds ratio and 95% confidence interval for studies (total of 662
patients) attempting to improve tissue perfusion before onset of tissue
hypoxic can be expected. Beneficial effect on mortality were seen.
(Modified from [30].)
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TTE/TEE is unlikely to replace already established monitoring
technologies in the ICU. Echocardiography provides different
information to the PAC. TTE/TEE has the disadvantage that
no continuous monitoring of cardiac function is possible. This
monitoring technique requires a high standard of training and
a lot of experience, and the costs are tremendous in compari-
son with other monitoring devices. This monitoring instrument
thus cannot be considered as a standard ‘screening’ device,
and it is too early to postulate that it should be used in lieu of
the PAC. Both monitoring methods, TTE/TEE and PAC, are
therefore more complementary than competitive, and both
techniques can be recommended for monitoring of hemo-
dynamics in the critically ill ICU patient (Fig. 3).
Monitoring of organ perfusion and
microcirculation
Inadequate tissue perfusion and oxygenation are likely to con-
tribute to the development of organ failures and increased
mortality in critically ill patients [44]. For this reason, assess-
ment of the adequacy of oxygen supply to organs and tissues
is essential. Monitoring of tissue oxygenation and organ
function in the clinical setting is largely based on measuring
traditional variables of resuscitation, such as global hemo-
dynamics, pulse oximetry, capillary refill, urine output, or indi-
rect biochemical markers. These parameters remain
insensitive indicators of dysoxia and are considered to be poor
surrogates for the oxygen availability at tissue levels, since
tissue oxygenation is determined by the net balance between
cellular oxygen supply and oxygen demand. Furthermore, the
fact that continuing regional tissue dysoxia can persist despite
the presence of an apparently adequate systemic blood flow,
pressure, and arterial oxygen content highlights the need for
specific indices of oxygenation at tissue level.
Methods to detect tissue dysoxia and oxygen debt can
grossly be subdivided into two groups; namely, techniques
directed at the assessment of oxygenation at the systemic
level, and monitoring techniques for measurements at the
organ level [45] (Table 1).
Indirect methods to measure tissue perfusion/
oxygenation
Oxygen delivery and oxygen consumption
Total body perfusion and oxygenation relies on adequate arte-
rial oxygen saturation (SaO2), hemoglobin concentration (Hb)
and CO. The total amount of convective oxygen delivered to
the peripheral tissue per minute (DO2) can be calculated as
DO2 =C O×C a O 2, with CaO2 = (Hb × 1.39 × SaO2). Under
steady state conditions, uptake of oxygen from the arterial
blood (VO2) represents the sum of all oxidative metabolic
reactions in the body. VO2 can be measured directly by the
use of metabolic carts and the analysis from expired gas, or
calculated from CO and arterial and mixed venous blood
samples. The ratio VO2/DO2 is the oxygen extraction ratio.
VO2/DO2 dependency occurs when the increase in oxygen
extraction can no longer fully compensate for the fall in DO2.
The relationship between DO2 and VO2 can therefore be
used to assess the adequacy of tissue oxygenation. However,
determination of DO2 and VO2 requires right heart catheteri-
zation to measure CO or is expensive if metabolic carts are
used to measure VO2. Moreover, the interpretation of
DO2/VO2 relationships has been criticized because of mathe-
matical coupling of data [46].
Mixed venous oxygen saturation
SvO2 can be readily measured from blood gas analysis
derived at the bedside either intermittently or continuously
with a fiberoptic PAC. Since the pulmonary artery carries
blood from all vascular beds of the organism, mixed venous
blood may represent the amount of oxygen in systemic circu-
lation that is left after passage through the tissues. SvO2
might thus serve as a parameter of global oxygenation. The
determinants of SvO2 are SaO2, systemic VO2, CO, and Hb,
with SvO2 = (SaO2 –V O 2) / (1.39 × Hb × CO). Accordingly,
an increase in VO2 and a decrease in Hb, CO and arterial
oxygenation will result in a decrease of SvO2. Interpretation of
SvO2 values might be difficult in conditions where DO2/VO2
relationships are altered. For example, arterial–venous micro-
circulatory shunting in sepsis may increase SvO2, thus pre-
tending adequate tissue oxygenation, while regional tissue
dysoxia is present [47].
Blood lactate
The importance of monitoring arterial lactate levels in critically
ill patients has been advocated [48]. Lactate is formed from
pyruvate by the cytosolic enzyme lactate dehydrogenase.
Lactate concentrations >2 mmol/l are generally considered a
biochemical indicator of inadequate oxygenation [49]. Circula-
tory failure with impaired tissue perfusion is the most common
Figure 3
Use of the pulmonary artery catheter and transesophageal
echocardiography (TEE) in the intensive care unit patient. PAP,
pulmonary artery pressure; CO, cardiac output; SvO2, mixed venous
oxygen saturation. (Modified from [43].)
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Initial assessment and general measurescause of lactic acidosis in intensive care patients. A number of
mechanisms other than impaired tissue oxygenation may
cause an increase in blood lactate, including an activation in
glycolysis, reduced pyruvate dehydrogenase activity, or liver
failure. Understanding the complex process of tissue lactate
production and utilization is therefore important to understand
the usefulness and potential limitations of monitoring blood
lactate levels. The presence of elevated lactate levels should
nevertheless prompt the clinician to initiate diagnostic proce-
dures for assessment of the circulatory status.
Tonometry
The hypovolemic patient is at risk of experiencing splanchnic
hypoperfusion with subsequent development of bacterial
translocation and systemic inflammatory response syndrome
[50]. Abnormalities of splanchnic perfusion may coexist with
normal systemic hemodynamic and metabolic parameters
[51]. Measurement of gastric intramucosal pH has emerged
as an attractive option for diagnosis and monitoring of
splanchnic hypoperfusion, and it appears to have more rele-
vance for predicting postoperative complications [52]. The
introduction of gastric or sigmoid mucosal tonometry for the
measurement of intraluminal carbon dioxide has enabled the
clinician to change focus from global oxygen transport to
regional tissue oxygenation. Tonometry in the present context
refers to the measurement of partial pressure of a gas. Mea-
suring the regional gastric carbon dioxide tension photometri-
cally with infrared spectrometry via a special gastric tube and
calculating the arterial-to-intramucosal partial pressure of
carbon dioxide difference and gastric intramucosal pH
provide valuable information about splanchnic perfusion [52].
Tonometer measurements might provide an insight in a region
of the body that is among the first to develop an inadequacy
of tissue oxygenation in circulatory shock and is the last to be
restored by resuscitation [53]. Gastrointestinal tonometry has
been evaluated in various situations during surgery and inten-
sive care [54]. As a result, it has been shown that prolonged
acidosis in the gastric mucosa might be a sensitive, but not
specific, predictor of outcome in critically ill patients [55].
Whether measurement of gastric mucosal pH or the
mucosal/venous carbon dioxide gradient reflects total
splanchnic perfusion is in doubt [56]. The prognostic value of
tonometry in the critically ill is not definitely clear. Only few
studies have demonstrated benefit from applying tonometry
[57]. Nevertheless, other measurements of hepatosplanchnic
perfusion (e.g. indocyanine green extraction, mucosal laser
Doppler flowmetry, remission spectrophotometry, or liver vein
oxygen saturation) are not widely accepted methods and are
still mostly used for research reasons.
Near-infrared spectroscopy
Near-infrared spectroscopy (NIRS) is a continuous non-inva-
sive method applying the principles of light transmission and
absorption to determine tissue oxygen saturation. NIRS mea-
sures oxygenated and deoxygenated Hb as well as the redox
state of cytochrome aa3 as an average value of arterial,
venous and capillary blood according to the law of
Lambert–Beer. Cytochrome aa3, the terminal cytochrome of
the respiratory chain, is responsible for approximately 90% of
cellular oxygen consumption through oxidative phosphoryla-
tion [58]. Since the redox state of cytochrome aa3 is primarily
determined by available oxygen, a decrease in cellular oxygen
delivery results in a reduction of oxidative phosphorylation
and a decreased oxidation level of cytochrome aa3. Monitor-
ing the redox state of cytochrome aa3 might therefore be a
key indicator of an impaired cellular oxidative metabolism and
tissue dysoxia. Although NIRS may be applied to almost any
organ, it has mainly been used in studies investigating cere-
bral or muscle oxygenation after different types of hypoxic
injuries [59]. The main limitation of NIRS in the clinical setting
is the inability to make quantitative measurements because of
the contamination of light by scatter and absorption [60].
Tissue oxygen tension
Monitoring tissue oxygen tension has become feasible for




Monitor Method Variables Global/regional Invasive/non-invasive
Systemic oxygenation Pulmonary artery catheter VO2/DO2/ERO2 Global Invasive
Mixed venous O2 saturation Pulmonary artery catheter–blood gas analyses SVO2 Global Invasive
Lactate Laboratory–enzymatic testing Lactate Global Invasive
Gastrointestinal tonometry Measurement of pCO2 in an air-filled or  prCO2/pCO2 gap, pHi Regional Minimally invasive
saline-filled balloon
Near-infrared spectroscopy Absorbance analysis of near-infrared light Hb/O2Hb, cytochrome aa3 Regional Non-invasive
Oxygen electrodes Polarographic probes pO2 Regional Minimally invasive
DO2, oxygen delivery; ERO2, oxygen extraction ratio; Hb/O2Hb, deoxygenated/oxygenated hemoglobin; pCO2 gap, arterial-to-intramucosal partial
pressure of carbon dioxide difference; pHi, gastric intramucosal pH; pO2, partial pressure of oxygen; prCO2, regional gastric carbon dioxide
tension; SvO2, mixed venous oxygen saturation; VO2, oxygen consumption.Clark electrodes. The polarographic oxygen sensors enable
us to measure oxygen partial pressure in tissues (ptiO2),
organs, and body fluids directly and continuously. The ptiO2
values correspond to oxygen availability on a cellular level and
provide information about oxygen supply and utilization in
specific tissue beds. Tissue oxygen tension has been mea-
sured successfully in intensive care as well as during neuro-
surgical procedures [61,62]. Studies on the critical threshold
of ptiO2 after traumatic brain injury showed that the absolute
level of oxygenation in the cerebral white matter was a reli-
able predictor of neurological outcome [61]. Organs like the
brain are not readily accessible, however, and thus are not
suitable for clinical routine monitoring. Monitoring muscle
partial pressure of oxygen might provide an early and reliable
indicator of stagnant blood flow and tissue dysoxia. It is easily
accessible and reacts to hemorrhage, resuscitation, and
shock on a similar time scale to that of the gastrointestinal
tract. Limiting factors in the use of polarographic oxygen
probes are the dependence of electrode currents on tissue
temperature, errors in ptiO2 readings due to tissue trauma
and edema by electrode insertion, or intravascular misplace-
ment of the oxygen sensors.
Conclusions
There are many monitoring instruments available and there
have been some outstanding developments in the past. One
major question rises whenever a new system is floating the
market: What is the ‘gold-standard’ for our monitoring instru-
ment? There is no doubt that the use of hemodynamic moni-
toring devices may yield additional information, and there is
no doubt that some of this information may be useful.
However, many of these devices may confuse and mislead
the responsible physician who has to care about his patient. It
is not always obvious that the more sophisticated the moni-
toring, the ‘better’ it is for the patients. The dictum is still ‘first,
do no harm’.
One of the burning problems in managing the ICU patient is
thus whether a specific monitoring technique has an impact
on patient outcome. Interestingly, it has never been shown
that a specific hemodynamic monitoring technique improves
outcome: neither ECG, oximetry or other well established
monitoring techniques have been proven in large trials to
have an impact on patient outcome. There is the risk that all
these techniques may delay or prolong what could otherwise
have been a quick, simple, and safe procedure, and they may
render the procedure much more expensive. The malfunction-
ing monitor and the wrongly trained intensivist may be a great
risk for the patient! Nevertheless, in the critically ill ICU
patient there is a need for something more than the senses to
monitor the patient’s hemodynamics, although some oppo-
nents of invasive hemodynamic monitoring wish to turn back
the clock to the old days of a ‘finger on the pulse’. The prop-
erly trained intensivist is a conditio sine qua non for managing
the critically ill patient because it is widely accepted that ‘a
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